The Emerging Role of Bcr-Abl-Induced Cystoskeletal Remodeling in Systemic Persistence of Leukemic Stem Cells

Author(s): Adrian Bartos, Patrycja M. Dubielecka

Journal Name: Current Drug Delivery

Volume 11 , Issue 5 , 2014

Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abl kinase plays a critical role in development and homeostasis of hematopoietic system. The importance of this kinase becomes apparent from the consequences of a specific, reciprocal translocation between chromosome 9 and chromosome 22 that yields a chimeric fusion protein, Bcr-Abl, in which the function of auto-regulatory mechanisms are inactivated. The resultant constitutively active kinase is responsible for development of a systemic leukemogenic phenotype. Studies employing currently available highly specific inhibitors, with high potency to block kinase activity, uncovered unanticipated characteristics of Bcr-Abl fusion protein. It became apparent that the kinase domain, with its primary significance for development and progression of leukemia, is not solely responsible for leukemogenic features of the Bcr-Abl transformed leukemic stem cells. In this review we summarize current understanding of non-enzymatic characteristics of Bcr-Abl, its effect on actin cytoskeleton, and its potential contribution to drug resistance and systemic persistence of leukemic stem cells.

Keywords: Actin cytoskeleton, Imatinib mesylate, Leukemic stem cells, Rho GTPases.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [582 - 591]
Pages: 10
DOI: 10.2174/156720181105140922123610
Price: $65

Article Metrics

PDF: 126